Mastaplex is an innovative startup based in New Zealand that has emerged from the thriving Agritech sector. Founded in 2015 and led by Dr Olaf Bork, Mastaplex is focused on revolutionizing veterinary point-of-care diagnostics. Their flagship product, Mastatest, has been a game-changer in the management of bovine mastitis within the dairy industry. This automated on-farm diagnostic tool is able to identify the presence of bacteria, its species, and antibiotic sensitivity, all within a remarkable 24-hour timeframe. Moreover, Mastatest has been well-received by farmers, who have reported improvements in milk productivity and farm profitability. Veterinarians have also found it to be a valuable tool in managing mastitis on-farm and in promoting the prudent use of antibiotics. Furthermore, Mastaplex recently secured a Venture Round investment on 09 November 2020, with Livestock Improvement Corporation (LIC) being the primary investor. For investors interested in contributing to Mastaplex's journey or learning more about the groundbreaking Mastatest, reaching out to the company is highly recommended.
No recent news or press coverage available for Mastaplex.